LXEO
Lexeo Therapeutics, Inc.
Company Overview
| Mkt Cap | $278.11M | Price | $10.01 |
| Volume | 1.04M | Change | +6.15% |
| P/E Ratio | -2.8 | Open | $9.41 |
| Revenue | -- | Prev Close | $9.43 |
| Net Income | $-98.3M | 52W Range | $1.45 - $11.72 |
| Div Yield | N/A | Target | $19.22 |
| Overall | 56 | Value | 60 |
| Quality | 34 | Technical | 75 |
No chart data available
Stock Overview
Updated DailyLexeo Therapeutics, Inc. (LXEO) is a leading diversified company in the business industry, currently trading at $10.01 with a market capitalization of $278.11 million. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating concerning quality fundamentals with a MarketXLS quality score of 34.
Today's trading session shows LXEO with a volume of 1.04 million shares. The stock opened down 0.21% from yesterday's close of $9.43. Current analyst estimates project earnings of $-2.31 per share for this year, with next year targeting $-1.47.
LXEO demonstrates strong technical indicators based on technical analysis. The company trades on the NSD exchange.
Key investment considerations for LXEO include average overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 92.0%. The stock shows fair valuation metrics based on valuation analysis.
Analysis generated on November 3, 2025 at 07:18 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | LXEO | $10.01 | +6.2% | 1.04M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Lexeo Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW